Safety and efficacy of imiquimod 5% cream applied once daily 3 days per week for the treatment of actinic keratoses in immunosuppressed organ transplant recipients-Results of a double blinded, European multi-centre study

2007 ◽  
Vol 56 (2) ◽  
pp. AB147
Keyword(s):  
Organ Transplant ◽  
Transplant Recipients ◽  
Multi Centre Study ◽  
Once Daily ◽  
Safety And Efficacy ◽  
Actinic Keratoses ◽  
Organ Transplant Recipients ◽  
Centre Study ◽  
Double Blinded

scholarly journals Use of Photodynamic Therapy for Treatment of Actinic Keratoses in Organ Transplant Recipients

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Christina Wlodek ◽  
Faisal R. Ali ◽  
John T. Lear
Keyword(s):  
Photodynamic Therapy ◽  
Organ Transplant ◽  
Solid Organ ◽  
Transplant Recipients ◽  
Actinic Keratoses ◽  
Organ Transplant Recipients ◽  
Skin Cancers ◽  
Effective Treatment Modality ◽  
Nonmelanoma Skin Cancers

Solid organ transplant recipients are predisposed to actinic keratoses (AK) and nonmelanoma skin cancers, owing to the lifelong immunosuppression required. Today, increasing numbers of organ transplants are being performed and organ transplant recipients (OTRs) are surviving much longer. Photodynamic therapy (PDT) is proving a highly effective treatment modality for AK amongst this susceptible group of patients. Following an overview of the pathogenesis of AK amongst OTRs, the authors review current safety and efficacy data and how this relates to the role of PDT for the treatment of AK in OTRs.

scholarly journals Incidence and Regression of Actinic Keratoses in Organ Transplant Recipients

2018 ◽  
Vol 98 (1) ◽  
pp. 77-81 ◽  
Author(s):  
Z Jiyad ◽  
L Marquart ◽  
P O'Rourke ◽  
A Green
Keyword(s):  
Organ Transplant ◽  
Transplant Recipients ◽  
Actinic Keratoses ◽  
Organ Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document